Brigham & Women's Hospital, Boston, U.S.
Recent research focus of reports from Brigham & Women's Hospital, Boston, U.S.
Published in Hospital Business Week, November 19th, 2006
This trend article about Brigham & Women's Hospital, Boston, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Cardiovascular outcomes trials show a significant benefit for high-dose vs. standard-dose statin therapy.
According to a recent report from the United States, "The purpose of this study was to conduct a meta-analysis that compares the reduction of cardiovascular outcomes with high-dose statin therapy versus standard dosing. Debate exists regarding the merit of more intensive lipid lowering with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Allergies
Scientists at RWTH, Department of Dermatology target allergies - Allergy & Immunology
Allergic disease takes heavy toll on children's health and quality of life - Amyotrophic Lateral Sclerosis
Cyberkinetics' BrainGate System enables thought-driven computer control for ALS patient in trial - Ascites Therapy
Research from Roche provides new data about ascites therapy - Autism
Data on autism in children described by researchers at Roche - Blood Safety
U.S. National Institutes of Health awards grant for clinical trial of bacterial test - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
